Linkevicius, MariusBonnin, Rémy AAlm, ErikSvartström, OlovApfalter, PetraHartl, RainerHasman, HenrikRoer, LouiseRäisänen, KatiDortet, LaurentPfennigwerth, NielsHans, Jörg BTóth, ÁkosBuzgó, LillaCormican, MartinDelappe, NiallMonaco, MonicaGiufrè, MariaHendrickx, Antoni PASamuelsen, ØrjanPöntinen, Anna KCaniça, ManuelaManageiro, VeraOteo-Iglesias, JesusPerez-Vazquez, MariaWestmo, KarinMäkitalo, BarbroPalm, DanielMonnet, Dominique LKohlenberg, Anke2023-05-172023-05-172023-05Euro Surveill. 2023 May;28(19):2300209.http://hdl.handle.net/20.500.12105/16087Whole genome sequencing data of 874 Escherichia coli isolates carrying bla NDM-5 from 13 European Union/European Economic Area countries between 2012 and June 2022 showed the predominance of sequence types ST167, ST405, ST410, ST361 and ST648, and an increasing frequency of detection. Nearly a third (30.6%) of these isolates were associated with infections and more than half (58.2%) were predicted to be multidrug-resistant. Further spread of E. coli carrying bla NDM-5 would leave limited treatment options for serious E. coli infections.engVoRhttp://creativecommons.org/licenses/by/4.0/Carbapenem-resistant EnterobacteralesEscherichia coliNDM-5CarbapenemaseCross-border importSurveillanceWhole genome sequencingEscherichia coliEscherichia coli InfectionsHumansbeta-LactamasesDrug Resistance, Multiple, BacterialEuropean UnionMicrobial Sensitivity TestsEuropeAtribución 4.0 Internacional371667622819230020910.2807/1560-7917.ES.2023.28.19.23002091560-7917Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinopen access